Cancer patients with mutations or variations in two genes -– PIK3CA and PTEN -– who have failed to respond to several, standard treatments, respond significantly better to anti-cancer drugs that inhibit these genes' pathways ...
Nov 7, 2012
0
0
Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory ...
Nov 7, 2012
0
0
Leading scientists in the field investigated the potential of RNA interference (RNAi) technology as a therapeutic intervention for down-regulating the expression of disease-associated genes. Project deliverables hold significant ...
Sep 20, 2012
0
0
Molecular imaging is effective for providing information about disease processes, and today's hybrid imaging systems have additional computed tomography (CT) technology on board for alignment and imaging structures. While ...
Jun 11, 2012
0
0
Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached ...
Jun 11, 2012
0
0
(Medical Xpress) -- European scientists dig into atherosclerotic plaque formation processes to investigate the part played by inflammation and vascular wall remodelling.
May 1, 2012
0
0
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
Mar 21, 2012
0
0
Millions of people suffer from type 2 diabetes. The leading cause of death in these patients is heart disease. Joseph Hill and colleagues, at the University of Texas Southwestern Medical Center, Dallas, have now identified, ...
Feb 13, 2012
0
0
Spanish researchers at CIC Biogune, the Cooperative Centre for Research into Biosciences and led by Dr. Maria Luz Martinez Chantar, have found a strong relationship between high levels of Hu antigen R (HuR) protein and the ...
Jan 26, 2012
0
0
Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent ...
Jan 12, 2012
0
0
